anonymous
Guest
anonymous
Guest
I’m an employee too. I agree. There isn’t any problem. Esperion positioned well for no normal access and extraordinary limitations to seeing or feeding anyone for the next 8 months. Internal medicine, family practice, cardiology and hospitals will be the first to open back to unfettered access to sales representatives by Q1’ 2021.ESPR has about 300 mil. coming in the coffers from hitting foreign regulatory milestones, so there is no immediate impending financial doom. Whether or not the products turn out to be a commercial success is TBD. I’m dubious, but the reality is the company does not have an immediate cash crisis.